Related by context. All words. (Click for frequent words.) 69 tkRNAi 66 DiLA2 65 humanized monoclonal 63 vivo RNAi 63 rxRNA 63 humanized monoclonal antibodies 62 Monoclonal 62 lipid nanoparticle 62 antisense inhibitor 62 anti CD3 61 Monoclonal antibody 61 Chemokine Receptor 61 mda 7 61 antisense inhibitors 61 murine model 61 Locked Nucleic Acid 61 siRNAs targeting 61 Cystic Fibrosis Transmembrane conductance 60 Onconase 60 peptide conjugated 60 Alfacell proprietary ribonuclease 60 potent suppressor 60 novel immunotherapeutic 60 Systemic Delivery 60 Plasmid DNA 60 cationic lipid 60 tkRNAi technology 60 microtubule inhibitor 60 virosome 60 benzimidazole 59 Glycosylation 59 recombinant adeno associated 59 AtuRNAi 59 Arcelis ™ 59 immunoregulation 59 Cyclosert TM 59 Oligonucleotide 59 mediated inhibition 59 siRNA sequences 59 adult mesenchymal stem 58 UsiRNAs 58 targeted antifolate 58 virus AAV 58 potently inhibit 58 HSP# inhibitors 58 Nucleotide 58 metabolite profiling 58 Immunotherapeutic 58 TLR9 agonist 58 deCODE chemistry 58 antimitotic 58 adenoviral 58 RNA antagonist 58 DNA Methylation 58 Squalamine 58 Somatostatin 58 lipid nanoparticles 58 Proteasome 58 AKT inhibitor 58 monoclonal antibody mAb 58 chimeric monoclonal antibody 58 Locked Nucleic Acid LNA 58 siRNA therapeutics 57 RNAi Therapeutic 57 plasmid DNA encoding 57 Aptamer 57 anticancer therapeutics 57 Assay Kits 57 Mucosal 57 Immunomodulatory 57 Immune Therapy 57 monoclonal antibody MAb 57 DNA plasmids 57 sd rxRNA 57 selective inhibition 57 Nicotinic 57 proteasome inhibitor 57 novel peptide 57 oral JAK1 57 Epidermal Growth Factor Receptor 57 ACTCellerate 57 Aurora Kinase 57 Polymerase 57 morpholino 57 radiolabelled 57 Electroporation 57 Protease Inhibitor 57 lentiviral vector 57 replicase 57 Cytotoxic 57 lentiviral 57 Monoclonal Antibody 57 irreversible inhibitor 56 aurora kinase 56 histone deacetylase inhibitor 56 hepatoma 56 Antiangiogenic 56 GRNVAC1 56 AAV vectors 56 ACC2 56 Potent Inhibitor 56 cyclin dependent kinase inhibitor 56 NOD mouse 56 tumor specific antigen 56 Interferon Gamma 56 Transmembrane 56 Protein Kinase C 56 Protease 56 anti CD# antibodies 56 CCR1 56 telomerase activators 56 Mutation Analysis 56 Protein Interactions 56 Therapeutic Vaccine 56 Janus Kinase 56 CXCR4 receptor 56 transgenic mouse models 56 Epitope 56 Lentiviral 56 Entry Inhibitor 56 Kinase Inhibitor 56 small molecule activators 56 siRNA therapeutic 56 peptidomimetic 56 Guanilib 56 Polymorphism 56 Cytochrome P# 56 stable nucleic acid 56 molecular biomarkers 56 Elvitegravir 55 TLR8 agonist 55 aurora kinase inhibitor 55 Camptothecin 55 SynCon TM DNA 55 Modrenal 55 nanoparticle formulation 55 subunit vaccines 55 ARRY # 55 Intradermal 55 pDNA vaccines 55 Tumor Targeting 55 HTRF 55 Cyclosert 55 antagomirs 55 intranasal delivery 55 protein tyrosine phosphatase 55 G Protein Coupled 55 anti angiogenic agent 55 antisense oligonucleotides 55 anti miRs 55 busulfan 55 envelope glycoprotein 55 Neuroprotection 55 Intracellular 55 annexin 55 Tyrosine Kinase Inhibitors 55 gag pol 55 Dendritic cell 55 Transgenic Mice 55 Thiovir 55 Ligands 55 Therapeutic Targets 55 Cathepsin S 55 murine models 55 radiotherapeutic 55 Modulates 55 Stapled Peptide 55 immunotherapeutic vaccine 55 Vitro Activity 55 DermaVir Patch 55 Protein Expression 55 Novasome R 55 liposomal formulation 55 Antisense 55 siRNA reagents 55 Reverse Transcriptase 55 Alkaline Phosphatase 55 Fibroblast 55 polyclonal antibody 55 Dendritic Cells 55 vinblastine 55 Antifungal 54 Apoptotic 54 NEUGENE R 54 bispecific 54 Pathway Inhibitor 54 adenoviral vector 54 microRNAs miR 54 radiolabeling 54 Kinase Inhibitors 54 A3 adenosine receptor 54 Novel Oral 54 HCV polymerase 54 uricase 54 TLR8 54 HepG2 cells 54 anti miRs targeting 54 EGIR 54 lentiviral vectors 54 ZFN 54 Anticalin ® 54 SNP Genotyping 54 MEK inhibitor 54 RNAi Therapeutics 54 GW# [003] 54 nucleotide analog 54 Polymerase Inhibitor 54 Safinamide 54 Inactivation 54 Nucleic Acid 54 LEAPS TM 54 HuMax 54 nucleotide analogs 54 Histone Deacetylase 54 Tumor Microenvironment 54 Small Molecule 54 Hydra Biosciences 54 Liposomal 54 liposome formulation 54 nanoviricides 54 plasmid DNA 54 Cytotoxic T 54 PhG alpha 1 54 immunostimulant 54 NEUGENE 54 Vaccine Adjuvants 54 PathHunter 54 Histone 54 Mutagenesis 54 DermaVir 54 siRNA duplexes 54 telomerase inhibitor 54 Taligen Therapeutics 54 radiolabeled monoclonal antibody 54 dAbs 54 Hsp# Inhibitor 54 pharmacophore 54 antisense molecules 54 5 HT4 receptor 54 ELISA kit 54 murine monoclonal antibody 54 BMS # 54 small molecule agonists 54 Metabolic Profiling 53 Technosphere ® 53 phosphatidylserine PS targeting 53 Presents Preclinical Data 53 Estrogen Receptor 53 Factor VIIa 53 agonist compounds 53 ChronVac C R 53 non nucleoside HCV 53 Morpholino 53 mGluR5 antagonist 53 radiolabeled 53 Anti angiogenic 53 Dicer Substrate 53 selective kinase inhibitor 53 nonviral 53 Ichor Medical Systems 53 Factor 5A 53 antitumoral 53 NS5A 53 immunoconjugate 53 selective antagonist 53 p# inhibitor 53 RNA Interference 53 small molecule activator 53 Retroviral 53 delipidation 53 vivo potency 53 Tarvacin 53 intratumoral injection 53 Cytotoxicity 53 NOD SCID mice 53 Progenitor Cells 53 Extracellular Matrix 53 Analogs 53 nucleic acid sequence 53 Liposome 53 immunoregulatory 53 PEGylated interferon 53 intravesical instillation 53 PNT# 53 Infectivity 53 p# antigen 53 predictive toxicology 53 Hepatocyte 53 flow cytometric 53 Immunostimulatory 53 NEUGENE antisense 53 nanomedicines 53 CEQ# 53 nucleoside analog 53 JAK2 inhibitor 53 lexidronam injection 53 PARI Pharma GmbH 53 cDNA microarray 53 stem cell mobilizer 53 Demonstrates Efficacy 53 heterologous 53 cytotoxicity assays 53 hERG 53 abacavir Ziagen 53 Novavax VLP vaccine 53 tumor antigen 53 rxRNA compounds 53 ALN TTR 53 Anti Phospholipid Therapy 53 cMET 53 PI3 kinase inhibitor 53 Clusterin 53 Deforolimus 53 ART# 53 preclinical efficacy 53 OHR/AVR# 53 Inflammatory Diseases 53 microdroplet based 52 topically administered 52 gamma secretase inhibitors 52 Tyrosine Kinase Inhibitor 52 Reports Preclinical Data 52 Macrocyclic 52 multikinase inhibitor 52 mGluR2 NAM 52 mouse xenograft models 52 isotype 52 maturation inhibitor 52 Bruton tyrosine kinase Btk 52 Transcription Factor 52 cynomolgus monkeys 52 Signaling Pathway 52 orally dosed 52 Novel Therapeutic 52 JVRS 52 TÎ ² 4 52 Tumor Suppressor 52 enzyme inhibitors 52 PORxin TM 52 EGFR HER2 52 Progenitor Cell 52 Crystallographic 52 ZFP TF 52 Cytoxan ® 52 Prolongs Survival 52 Talabostat 52 small molecule tyrosine 52 DNA Polymerase 52 Galectin 52 cytochrome P 52 SGLT 52 kinase assay 52 Protein Biomarker 52 PARP Inhibitor 52 Neuropeptide Y 52 Protein Kinase 52 Genisphere 52 Innate Immunity 52 azacytidine 52 Associated Diarrhea 52 compound AEZS 52 eIF4E 52 PSMA ADC 52 VitiGam 52 Illumina Solexa 52 peptide antigens 52 proprietary encapsulation 52 Cytometry 52 TRAIL receptors 52 PI3K inhibitor 52 RAV# 52 Prodrug 52 histone deacetylase 52 pan HDAC inhibitor 52 Mammalian Cells 52 radionuclide therapy 52 cleavable linker 52 retroviral vectors 52 TNF Alpha 52 Preclinical Study 52 neuroblastoma tumors 52 Ataluren 52 FUS1 52 chemokine receptor 52 IKK epsilon 52 S#P# 52 Transdermal Delivery 52 Temsirolimus 52 IgG1 antibody 52 flavopiridol 52 Alligator Bioscience 52 VNP#M 52 aerosol formulation 52 MediVas 52 BiTE Antibody 52 telomerase activator 52 paclitaxel Taxol 52 ESBA# 52 kinase profiling 52 Biologic Therapy 52 NMDA antagonists 52 Solexa sequencing 51 Anticalins 51 nucleotide analogues 51 HQK 51 depsipeptide 51 bryostatin 51 KSP inhibitor 51 prolyl hydroxylase inhibitors 51 Genotypes 51 antibody blinatumomab MT#/MEDI-# 51 Tumor Necrosis Factor 51 hybridoma 51 Etravirine 51 ENMD # 51 ALK inhibitor 51 HDAC Inhibitor 51 adducts 51 Nanobodies 51 sd rxRNA compounds 51 Diabetic Neuropathy 51 HTS assay 51 Protease Inhibitors 51 Transcriptome 51 adenovirus vectors 51 acyltransferase 51 HDL Mimetic Peptide 51 Therapeutic Agents 51 nasally delivered 51 prophylactic vaccine 51 Zinc Finger Nuclease 51 Anticancer Agents 51 LT NS# 51 Convection Enhanced Delivery 51 Conjugates 51 Anti Tumor 51 biotinylated 51 anti CD3 antibody 51 RNase L 51 Successfully Completes Phase 51 histone acetyltransferase 51 Cancer Vaccines 51 Micromet BiTE 51 Interferon Beta 51 Pegylated Interferon 51 Valopicitabine 51 HER2 ErbB2 51 proteasome inhibitors 51 NanoEmulsion 51 Cardiotoxicity 51 GPCR targets 51 Inflammatory Arthritis 51 NRTI resistance 51 cDNAs 51 IgM antibody 51 druggable targets 51 MGd 51 allergic airway inflammation 51 oligonucleotide microarrays 51 antimicrobial peptide 51 Tesetaxel 51 cellular cytotoxicity 51 Vivecon 51 eFlow Technology 51 Cannabinoid 51 lipidoid 51 JAK2 inhibitors 51 ghrelin antagonists 51 DNA oligonucleotides 51 AVI NEUGENE 51 CRLX# 51 QT Prolongation 51 Cell Differentiation 51 Mimetics 51 affinity ligands 51 Bosutinib 51 nucleoside analogues 51 Replacement Therapy 51 GRNCM1 51 Hematopoietic Stem Cells 50 Homeostasis 50 immunostimulatory 50 MET VEGFR2 50 Biological Therapy 50 Interferon alpha 50 XTEN 50 EZN 50 Corgentin 50 reversible inhibitor 50 Ion Channels 50 Antimalarial 50 transient transfection 50 gp# protein [002] 50 plasmid DNA vaccine 50 vivo preclinical 50 antiangiogenic agent 50 Monoclonal Antibodies 50 LungSign TM 50 AdnaTest 50 antisense oligonucleotide 50 Molecular Evolution 50 fosbretabulin 50 Chemoprevention 50 Mesenchymal Stem Cells 50 thyroid hormone receptor 50 Inhibits Growth 50 TAKSTA 50 Gleevec resistant 50 soluble receptor 50 IFN α 50 metabolite identification 50 epoetin alpha 50 Interferon alfa 50 Glypromate 50 cidofovir 50 tumor lysate 50 Aplidin R 50 Epitopes 50 Retrovirus 50 Motility 50 Allogeneic 50 SuperAntibody 50 miRview meso 50 BiTE 50 Adult Stem Cell Therapy 50 antisense compounds 50 Cell Adhesion 50 Oncogene 50 NK1 50 Parathyroid Hormone 50 Degarelix 50 dotLab System 50 Tropism 50 Rigel R# 50 metastatic neuroendocrine tumors 50 verteporfin 50 CCR5 antagonist 50 Enhanze Technology 50 histone deacetylase HDAC inhibitor 50 CCR2 50 pharmacodynamic markers 50 biophysical techniques 50 nicotinic acetylcholine receptor 50 inhaled AAT 50 ON #.Na 50 Ocular Diseases 50 interfering RNAs 50 ghrelin agonist 50 IRHs 50 annexin V 50 Drug Formulation 50 Decitabine 50 GHRH 49 fusion inhibitor 49 nucleosides 49 Cancer Stem Cells 49 Geron telomerase inhibitor 49 PI3K/mTOR 49 Tesmilifene 49 OvaRex MAb 49 NSCLC tumors 49 BAL# [002] 49 delafloxacin 49 Fulvestrant 49 DUROS 49 CCX# 49 Bevasiranib 49 Myeloperoxidase 49 direct thrombin inhibitors 49 Kahalalide F 49 Affymetrix GeneChip 49 Targeted Therapy 49 Vaxart 49 Protein Synthesis 49 Present Preclinical Data 49 Epithelium 49 Macrophage 49 Preclinical Data 49 Introgen ADVEXIN 49 Receptor Antagonists 49 iron dextran 49 APiX 49 BAL# [001] 49 Diabetic Foot Ulcer 49 PSMA antibody 49 Denufosol 49 Phase IIA 49 HDL Selective Delipidation 49 Hormone Refractory Prostate Cancer 49 Anticancer Drug 49 Neoplasms 49 Quantitative PCR 49 Elan NanoCrystal 49 Antiviral Therapy 49 transcranial Doppler ultrasound 49 small interfering RNA 49 immunogens 49 therapeutically relevant 49 Homology 49 antiviral compounds 49 oral renin inhibitor 49 AAGP 49 Interferon Alpha 49 AEMD 49 Fenretinide 49 VentiRx Pharmaceuticals 49 CLL SLL 49 recombinant protein 49 Induced Pluripotent Stem Cells 49 QTL mapping 49 novel prodrug 49 REMINYL ® 49 BAC clones 49 Small Molecule Repository 49 Thrombin 49 subcutaneous immunoglobulin 48 shRNA 48 Symadex 48 Novel Therapeutics 48 Immunohistochemical analysis 48 Peptide 48 Zinc Finger Nucleases 48 Epothilone 48 microsatellite markers 48 Stakeholder Opinions 48 Proliferative 48 cDNA sequencing 48 GLP toxicology studies 48 Btk inhibitor 48 ALN HTT 48 Pertuzumab 48 Bruton tyrosine kinase 48 protein microarray 48 Small Molecules 48 Sym# 48 rAAV 48 peptidic 48 Lysosomal 48 Kinase inhibitor 48 vitamin D analogs 48 Signaling Pathways 48 Chemokine 48 Cytoplasmic 48 hydroxamic acid 48 #th Interscience Conference 48 adenosine receptor 48 Listeria vaccine 48 Preclinical Evaluation 48 Phase 2a Trial 48 trastuzumab Herceptin ® 48 Dasatinib 48 Conjugation 48 ISF# 48 HCV polymerase inhibitor 48 solithromycin 48 Thymosin beta 4 48 Anticancer 48 Gene Silencing 48 microtubule targeting 48 FASN 48 SYN# 48 Neurotrophic Factor 48 Potent Antiviral Activity 48 Photodynamic Therapy 48 viral kinetics 48 Mutational 48 vorinostat 48 cDNA libraries 48 talabostat 48 RezularTM 48 bispecific antibody 48 Beta Amyloid 48 vitro cytotoxicity 48 Treat Parkinson Disease 48 PBMCs 48 EGFR inhibition 48 PEG SN# 48 1α 48 systemic RNAi therapeutic 48 Phase Ib Clinical Trial 48 Dalbavancin 48 Tumor Angiogenesis 48 Biomarker Study 48 oligonucleotides 47 transcriptase inhibitors NNRTIs 47 Tumor Response 47 Nilotinib 47 Pgp 47 RefSeq 47 abstr 47 AZT 3TC 47 Carfilzomib 47 Receptor Antagonist 47 Antiviral Activity 47 Molecular Mechanisms 47 Pharmacodynamics 47 intradermal injections 47 Sipuleucel T 47 Hepatocellular Carcinoma 47 aminolevulinic acid 47 immunomodulatory agents 47 IFOS 47 ZFNs 47 Tumorgraft 47 Tigecycline 47 Highly Potent 47 TLR antagonists 47 Nucleic Acids 47 fluorescently tagged 47 cyclophilin inhibitor 47 pDNA vaccine 47 NABTT 47 DNA ligase 47 Inhalation Solution 47 MenACWY 47 immune modulation 47 VRX# [001] 47 AIR# [001] 47 #:#-# [033] 47 Allosteric 47 HCV Genotype 47 maturation inhibitors 47 Assay Kit 47 Protein Structure 47 bioresorbable stent 47 pertuzumab 47 OROS R 47 R roscovitine 47 IFN alpha 47 Radezolid 47 entitled Synergistic 47 PEG IFN 47 peginterferon alpha 47 SMT C# 47 siRNA 46 aminolevulinic acid ALA 46 KLF4 46 drug zotarolimus 46 Universal Flu Vaccine 46 ZYBRESTAT TM 46 Salivary 46 SR# [004] 46 human microdosing 46 Nat Biotechnol 46 Oligonucleotides 46 microparticle 46 Immunosuppression 46 Blinatumomab 46 NN# [001] 46 inhibitor RG# 46 streptococcal vaccine 46 Virtual Histology 46 Therapeutic Proteins 46 indibulin 46 pharmacodynamic properties 46 recombinant adenovirus 46 Transcranial Magnetic Stimulation TMS 46 Antiviral 46 TLR7 46 Novel Therapies 46 Inflammatory Disease 46 p# biomarker 46 Pramlintide 46 oligonucleotide 46 Oritavancin 46 PPMO 46 Bioral ® 46 Late Breaker 46 Bremelanotide 46 Neuroendocrine Tumor 46 CCR5 mAb 46 combinability 46 MAQC 46 Aneuploidy 46 quantitative RT PCR 46 Intrinsic Bioprobes 46 Lucanix 45 darunavir Prezista 45 antisense 45 Controlled Release 45 Solid Tumors 45 Neural Stem Cells 45 ritonavir boosted 45 FVIIa 45 Renal Cell Cancer 45 microdose 45 Biojector ® 45 Chemotherapeutic Agents 45 administered subcutaneously 45 LHRH 45 cytotoxics 45 protein kinase inhibitors 45 Microarray analysis 45 Targeted Therapeutics 45 genitourinary cancers 45 Subsets 45 dexpramipexole 45 atazanavir Reyataz 45 melanoma antigens 45 Plasma Protein 45 Dicer substrate 45 AACR Meeting 45 ASGCT 45 Targeted Therapies 45 Clinical Outcome 45 interfering RNA 45 Pimavanserin 45 Pharmacodynamic 45 Telbivudine 45 MaxCyte STX 45 Hedgehog pathway inhibitor 45 Bevirimat 45 integrase 45 Exome 45 Solorel TM 45 MAb 45 preclinically 45 Clinical Trial Data 45 preclinical pharmacokinetic 45 Bionanotechnology 44 novel vascular disrupting 44 antiepileptics 44 Hepatic Encephalopathy 44 trodusquemine 44 Vacc 4x 44 JAK Inhibitor 44 Thymosin 44 HIF PH inhibitors 44 Placebo Controlled Trial 44 #:#-# [031] 44 RNA seq 44 eTag assay 44 sd rxRNAs 44 Phase Ib clinical 44 Abstract Number 44 Autoimmune Diseases 44 intravenous recombinant 44 Refractory Angina 44 ZFP Therapeutic TM 44 Nektar PEGylation technology 44 Pharmacologic 44 imatinib mesylate Gleevec 44 Btk Inhibitor 44 Percutaneous Tibial Nerve Stimulation 44 Cytogenetic 44 Exemestane 44 #:#-# [035] 44 Disease Diagnosis 44 See CLINICAL PHARMACOLOGY 44 Adjuvant Breast Cancer 44 SMIP 44 tacrolimus ointment 44 Glatiramer acetate 44 Therapeutic Effects 43 Immunogenicity 43 mRNA splicing 43 5 HT2C receptor 43 Contrast Agents 43 Biotherapy 43 Renal Insufficiency 43 quadrivalent human papillomavirus 43 Molecular Medicine Tri 43 Cytokines 43 generation antisense 43 Cancer Therapies 43 Poster Discussion 43 Adefovir 43 ECCMID 43 mRNA Seq 43 Beta catenin pathway 43 Protein Therapeutics 43 TLR antagonist 43 viral vectors 43 AASLD Meeting 43 Targeted Anticancer Therapies 43 KRN# 42 Aethlon Hemopurifier R 42 Tumor Progression 42 SNALP formulations 42 ICAAC IDSA 42 photosensitizing agent 42 HYLENEX recombinant 42 Recombumin 42 ASCO GU 42 Poster Presentation 42 Tablet Formulation 42 Pharmacological 42 TPV r 42 ASH Annual Meeting 42 Talotrexin 42 Ultrafast Insulin 42 Photodynamic therapy 42 Placebo Controlled Study 42 Oral Presentations 42 AACR NCI EORTC 42 PegIFN RBV 42 IFN beta 42 lymphocyte counts 42 Lung Tumors 42 ABRF 41 #:#-# [003] 41 Oral Presentation 41 Clinical Evaluation 41 estrogen estradiol 41 NNR Therapeutics 41 Genvec 41 Angiogenesis 41 Therapeutic Approaches 41 peptide 41 OpenArray platform 41 Clinical Relevance 41 Bendavia 41 interstitial brachytherapy 41 Regimens 41 DAS# Fludase ® 41 levodopa induced dyskinesia 41 Breast Brachytherapy 41 Keystone Symposium 41 Pharmaprojects 41 Phase III randomized controlled 41 Microbicide 41 BioProcess International 41 Hydroxyurea 41 latanoprost 41 Oral Session 40 recurrent glioma 40 Nanocoatings 40 pharmacokinetic PK profile 40 Cambridge Healthtech Institute 40 Optical Coherence Tomography 40 Eligen R B# 40 GTCbio 3rd 39 Schizophrenia Treatment 39 pharmacokinetic characteristics 39 sipuleucel T 39 Mechanistic 39 liposome injection 39 Scientific Poster Session 39 Novel Approaches 39 Hsp# inhibitor STA 39 ritonavir boosting 39 teriflunomide 39 CROI 39 Levulan Photodynamic Therapy 39 AACR #st Annual Meeting 39 Btk Inhibitor PCI 39 mg kg cohorts 38 interferon lozenges 38 nd Annual Meeting 38 ASCO abstract 38 AACR San Antonio 38 BMS# 38 Intervention Trial 37 Thermo Scientific booth 37 Ocular Disease 37 Windhover Therapeutic Area 37 AAPS Annual Meeting 37 MaxCyte 37 Reproductive Toxicology 37 Keystone Symposia 37 Epigenome 37 ASGT 37 NMES 37 TH PO# 37 Abstract P# [002] 37 Selective Cardiac Myosin Activator 37 AGBT 36 ICAAC 36 SABCS 36 pramlintide metreleptin combination 36 Podium Presentation 36 Lucentis ranibizumab Genentech 36 Zenvia Phase III 36 Gastrointestinal Cancers Symposium 36 Sprague Dawley rats 36 Opportunistic Infections CROI 36 ACR ARHP 35 quadrivalent HPV vaccine 35 Exenatide Byetta 35 Prostate Disease 35 Genitourinary Cancers Symposium 35 Therapeutics TCT 34 GTCbio 34 Breast Cancer Symposium 33 Biomerk Tumorgraft TM 33 Retroviruses 33 ADA Scientific Sessions 33 ASCO Breast Cancer 32 AAEP Convention 32 ASCO Annual Meeting 32 AASLD 31 NSTI Nanotech 31 Halloysite Nanotubes 31 LabAutomation 31 Planet xMAP USA 30 Digestive Diseases Week 30 Prostate Cancer Symposium 30 VEITHsymposium 24 Transcatheter Cardiovascular Therapeutics TCT